Regulatory Guidance

The Consortium facilitates dialog with regulatory bodies, such as the U.S. Food and Drug Administration, in order to provide a comprehensive understanding of the regulatory climate and help develop needed standards for evaluating cancer immunotherapies. Member-only workshops and working groups aim to provide comments on guidelines released by regulatory agencies.